Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®)

F. Gentile, D. Castini, M. Ornaghi, E. Mangiarotti, M. Garbin, R. Ravaglia, M. Gioventu, A. Mantero, R. Corno, A. Limido, F. Morandi, C. Fiorentini, A. Pezzano, S. Repetto, T. Haider, H. Morris, C. Marelli

Research output: Contribution to journalArticle

Abstract

Previous animal studies have suggested the feasibility of echocontrastographic cardiac output evaluation applying the principles of dye-dilution theory. The present study was undertaken in order to verify the feasibility of cardiac output evaluation in humans using a sonicated albumin transpulmonary echocontrast agent (Infoson®). Thirty-seven patients, with a mean age of 57 ± 10 years, who underwent a complete invasive hemodynamic evaluation for clinical reasons, were studied. Infoson® at the dosage of 0.20 ml/kg was administered intravenously to all patients immediately after the hemodynamic study, and the apical 4-chamber view was visualized and recorded on a videotape during contrast injection. The echocardiographic images were subsequently off-line digitized and videodensitometrically analyzed, using a dedicated system (TomTec-Freeland), in order to obtain the time-intensity curve of the left ventricular opacification. After a γ-variate fitting, the following parameters were obtained from the time-intensity curve: the area under the curve, the area under the washout phase, the maximal videointensity, the duration of the curve, the slope of the washout phase and the half-time decay of the curve. After the correlation of each of these parameters with thermodilution cardiac output and cardiac index were separately tested, a multiple regression analysis was performed entering all the videodensitometric parameters and heart rate. Finally, a stepwise multiple regression analysis was performed. Both for cardiac output and cardiac index, only the half-time decay and duration of the curve, and heart rate were retained in the final predictive equation. Our results confirm the existence of a significant correlation between some videodensitometric parameters of the left ventricular opacification time-intensity curve obtained by echocontrastography and the thermodilution cardiac output and suggest the feasibility of cardiac output estimation by means of left ventricular opacification videodensitometry using peripheral venous administration of Infoson®.

Original languageEnglish
Pages (from-to)131-134
Number of pages4
JournalCardiovascular Imaging
Volume9
Issue number4
Publication statusPublished - 1997

Fingerprint

Intravenous Administration
Cardiac Output
Albumins
Thermodilution
Heart Rate
Hemodynamics
Regression Analysis
Videotape Recording
Area Under Curve
Albunex
Coloring Agents
Injections

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Gentile, F., Castini, D., Ornaghi, M., Mangiarotti, E., Garbin, M., Ravaglia, R., ... Marelli, C. (1997). Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®). Cardiovascular Imaging, 9(4), 131-134.

Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®). / Gentile, F.; Castini, D.; Ornaghi, M.; Mangiarotti, E.; Garbin, M.; Ravaglia, R.; Gioventu, M.; Mantero, A.; Corno, R.; Limido, A.; Morandi, F.; Fiorentini, C.; Pezzano, A.; Repetto, S.; Haider, T.; Morris, H.; Marelli, C.

In: Cardiovascular Imaging, Vol. 9, No. 4, 1997, p. 131-134.

Research output: Contribution to journalArticle

Gentile, F, Castini, D, Ornaghi, M, Mangiarotti, E, Garbin, M, Ravaglia, R, Gioventu, M, Mantero, A, Corno, R, Limido, A, Morandi, F, Fiorentini, C, Pezzano, A, Repetto, S, Haider, T, Morris, H & Marelli, C 1997, 'Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®)', Cardiovascular Imaging, vol. 9, no. 4, pp. 131-134.
Gentile F, Castini D, Ornaghi M, Mangiarotti E, Garbin M, Ravaglia R et al. Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®). Cardiovascular Imaging. 1997;9(4):131-134.
Gentile, F. ; Castini, D. ; Ornaghi, M. ; Mangiarotti, E. ; Garbin, M. ; Ravaglia, R. ; Gioventu, M. ; Mantero, A. ; Corno, R. ; Limido, A. ; Morandi, F. ; Fiorentini, C. ; Pezzano, A. ; Repetto, S. ; Haider, T. ; Morris, H. ; Marelli, C. / Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®). In: Cardiovascular Imaging. 1997 ; Vol. 9, No. 4. pp. 131-134.
@article{50a6b62704614147b7426aaa999dcb1e,
title = "Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson{\circledR})",
abstract = "Previous animal studies have suggested the feasibility of echocontrastographic cardiac output evaluation applying the principles of dye-dilution theory. The present study was undertaken in order to verify the feasibility of cardiac output evaluation in humans using a sonicated albumin transpulmonary echocontrast agent (Infoson{\circledR}). Thirty-seven patients, with a mean age of 57 ± 10 years, who underwent a complete invasive hemodynamic evaluation for clinical reasons, were studied. Infoson{\circledR} at the dosage of 0.20 ml/kg was administered intravenously to all patients immediately after the hemodynamic study, and the apical 4-chamber view was visualized and recorded on a videotape during contrast injection. The echocardiographic images were subsequently off-line digitized and videodensitometrically analyzed, using a dedicated system (TomTec-Freeland), in order to obtain the time-intensity curve of the left ventricular opacification. After a γ-variate fitting, the following parameters were obtained from the time-intensity curve: the area under the curve, the area under the washout phase, the maximal videointensity, the duration of the curve, the slope of the washout phase and the half-time decay of the curve. After the correlation of each of these parameters with thermodilution cardiac output and cardiac index were separately tested, a multiple regression analysis was performed entering all the videodensitometric parameters and heart rate. Finally, a stepwise multiple regression analysis was performed. Both for cardiac output and cardiac index, only the half-time decay and duration of the curve, and heart rate were retained in the final predictive equation. Our results confirm the existence of a significant correlation between some videodensitometric parameters of the left ventricular opacification time-intensity curve obtained by echocontrastography and the thermodilution cardiac output and suggest the feasibility of cardiac output estimation by means of left ventricular opacification videodensitometry using peripheral venous administration of Infoson{\circledR}.",
author = "F. Gentile and D. Castini and M. Ornaghi and E. Mangiarotti and M. Garbin and R. Ravaglia and M. Gioventu and A. Mantero and R. Corno and A. Limido and F. Morandi and C. Fiorentini and A. Pezzano and S. Repetto and T. Haider and H. Morris and C. Marelli",
year = "1997",
language = "English",
volume = "9",
pages = "131--134",
journal = "Cardiovascular Imaging",
issn = "1120-0421",
publisher = "C E P I - Centro Editoriale Pubblicitario Italiano s.r.l.",
number = "4",

}

TY - JOUR

T1 - Echocontrastographic evaluation of cardiac output using intravenous administration of sonicated human albumin (Infoson®)

AU - Gentile, F.

AU - Castini, D.

AU - Ornaghi, M.

AU - Mangiarotti, E.

AU - Garbin, M.

AU - Ravaglia, R.

AU - Gioventu, M.

AU - Mantero, A.

AU - Corno, R.

AU - Limido, A.

AU - Morandi, F.

AU - Fiorentini, C.

AU - Pezzano, A.

AU - Repetto, S.

AU - Haider, T.

AU - Morris, H.

AU - Marelli, C.

PY - 1997

Y1 - 1997

N2 - Previous animal studies have suggested the feasibility of echocontrastographic cardiac output evaluation applying the principles of dye-dilution theory. The present study was undertaken in order to verify the feasibility of cardiac output evaluation in humans using a sonicated albumin transpulmonary echocontrast agent (Infoson®). Thirty-seven patients, with a mean age of 57 ± 10 years, who underwent a complete invasive hemodynamic evaluation for clinical reasons, were studied. Infoson® at the dosage of 0.20 ml/kg was administered intravenously to all patients immediately after the hemodynamic study, and the apical 4-chamber view was visualized and recorded on a videotape during contrast injection. The echocardiographic images were subsequently off-line digitized and videodensitometrically analyzed, using a dedicated system (TomTec-Freeland), in order to obtain the time-intensity curve of the left ventricular opacification. After a γ-variate fitting, the following parameters were obtained from the time-intensity curve: the area under the curve, the area under the washout phase, the maximal videointensity, the duration of the curve, the slope of the washout phase and the half-time decay of the curve. After the correlation of each of these parameters with thermodilution cardiac output and cardiac index were separately tested, a multiple regression analysis was performed entering all the videodensitometric parameters and heart rate. Finally, a stepwise multiple regression analysis was performed. Both for cardiac output and cardiac index, only the half-time decay and duration of the curve, and heart rate were retained in the final predictive equation. Our results confirm the existence of a significant correlation between some videodensitometric parameters of the left ventricular opacification time-intensity curve obtained by echocontrastography and the thermodilution cardiac output and suggest the feasibility of cardiac output estimation by means of left ventricular opacification videodensitometry using peripheral venous administration of Infoson®.

AB - Previous animal studies have suggested the feasibility of echocontrastographic cardiac output evaluation applying the principles of dye-dilution theory. The present study was undertaken in order to verify the feasibility of cardiac output evaluation in humans using a sonicated albumin transpulmonary echocontrast agent (Infoson®). Thirty-seven patients, with a mean age of 57 ± 10 years, who underwent a complete invasive hemodynamic evaluation for clinical reasons, were studied. Infoson® at the dosage of 0.20 ml/kg was administered intravenously to all patients immediately after the hemodynamic study, and the apical 4-chamber view was visualized and recorded on a videotape during contrast injection. The echocardiographic images were subsequently off-line digitized and videodensitometrically analyzed, using a dedicated system (TomTec-Freeland), in order to obtain the time-intensity curve of the left ventricular opacification. After a γ-variate fitting, the following parameters were obtained from the time-intensity curve: the area under the curve, the area under the washout phase, the maximal videointensity, the duration of the curve, the slope of the washout phase and the half-time decay of the curve. After the correlation of each of these parameters with thermodilution cardiac output and cardiac index were separately tested, a multiple regression analysis was performed entering all the videodensitometric parameters and heart rate. Finally, a stepwise multiple regression analysis was performed. Both for cardiac output and cardiac index, only the half-time decay and duration of the curve, and heart rate were retained in the final predictive equation. Our results confirm the existence of a significant correlation between some videodensitometric parameters of the left ventricular opacification time-intensity curve obtained by echocontrastography and the thermodilution cardiac output and suggest the feasibility of cardiac output estimation by means of left ventricular opacification videodensitometry using peripheral venous administration of Infoson®.

UR - http://www.scopus.com/inward/record.url?scp=0031399105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031399105&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031399105

VL - 9

SP - 131

EP - 134

JO - Cardiovascular Imaging

JF - Cardiovascular Imaging

SN - 1120-0421

IS - 4

ER -